 <h1>EndaCof-Plus Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>dexchlorpheniramine / hydrocodone / phenylephrine</i></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about dexchlorpheniramine / hydrocodone / phenylephrine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name EndaCof-Plus.</p><p><i>Applies to dexchlorpheniramine/hydrocodone/phenylephrine: oral liquid, oral syrup</i></p><h3>General</h3><p>.<sup>[Ref]</sup></p><p id="ref_1">1. US Food and Drug Administration (US FDA) "Approved Risk Evaluations and Mitigation Strategies (REMS): Opioid Analgesic REMS. Available from: URL: https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&amp;REMS=17"   ([2018, Sep 18]):</p><h2>More about EndaCof-Plus (dexchlorpheniramine / hydrocodone / phenylephrine)</h2><ul class="more-resources-list more-resources-list-general">
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: upper respiratory combinations</li>
<li>FDA Alerts (1)</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Cough and Nasal Congestion</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>